Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your gut releases after eating — slowing digestion, reducing appetite, and signaling your brain that you're full. At low doses, the effect is subtle. At therapeutic doses, appetite suppression becomes significant.

The titration schedule exists because your GI tract needs time to adapt. Starting at a full therapeutic dose almost guarantees nausea, vomiting, or both. The slow ramp-up lets your body adjust while still building toward effective blood levels.

Most semaglutide protocols hold each dose for four weeks before stepping up — and that's not arbitrary. Clinical data supporting Wegovy (brand-name semaglutide for weight loss) used a 16-to-20-week titration before patients reached the 2.4 mg maintenance dose.

The chart below reflects the standard titration schedule used in clinical weight loss protocols. Individual providers may adjust timing based on tolerability, so your actual schedule may differ.

Some providers use a simplified four-step schedule that skips 1.7 mg entirely, jumping from 1.0 mg straight to 2.4 mg. Others hold patients at 1.0 mg or 1.7 mg if that dose is producing results with fewer side effects. There's no universal rule that every patient must reach 2.4 mg.

Weeks 1–4: The Adjustment Window

At 0.25 mg, most people notice very little. Some mild nausea after injection is common, especially in the first few days. Appetite suppression is minimal at this dose — the goal here is tolerability, not weight loss. Don't expect dramatic results yet.

Weeks 5–8: Appetite Starts to Shift

At 0.5 mg, most patients begin noticing they feel full faster and think about food less between meals. Nausea can tick up slightly with the dose change but usually settles within a week. This is often when the scale starts to move.

Weeks 9–12: The Inflection Point

The 1.0 mg dose is where semaglutide's appetite-suppressing effect becomes clearly noticeable for most people. Portions naturally shrink. Cravings for high-calorie foods often ease. Some patients report mild fatigue or constipation at this stage — both manageable with hydration and small dietary adjustments.

Weeks 13–16: Closing In on Maintenance

At 1.7 mg, you're close to the full therapeutic dose. Weight loss typically accelerates here for patients who've been consistent, and side effects from earlier phases often stabilize by this point.

Week 17 Onward: Maintenance Dose

The 2.4 mg weekly dose is the maintenance target for weight management. Most patients stay here for the duration of their treatment. Some providers allow dose reductions if side effects are affecting quality of life, even when the medication is otherwise working well.

The titration schedule is a guideline, not a rule. If nausea, vomiting, or significant GI distress makes a dose increase hard to tolerate, your provider may recommend holding the current dose for an additional four weeks before stepping up.

Signs you may need to slow the titration:

• Nausea that lasts more than three to four days after each injection
• Vomiting more than once per week
• Difficulty eating adequate calories or staying hydrated
• Fatigue significant enough to interfere with daily function

Slowing down doesn't reduce long-term effectiveness. Reaching the maintenance dose a few weeks later is far better than stopping treatment entirely because of avoidable side effects.

Semaglutide is injected subcutaneously once per week. Picking a consistent day matters — the medication builds to a steady-state concentration over time, and irregular dosing disrupts that stability.

Common injection sites include the abdomen, outer thigh, and upper arm. Rotating sites reduces the chance of localized skin reactions. If you miss a dose by fewer than five days, take it as soon as you remember. If you're within two days of your next scheduled dose, skip the missed one and continue your regular schedule.

Semaglutide is used in two different clinical contexts with different dosing targets. Ozempic, approved for type 2 diabetes management, uses a maximum dose of 2.0 mg per week. Wegovy, approved for chronic weight management, targets 2.4 mg.

Compounded semaglutide formulations — which are not FDA-approved drugs — are sometimes prescribed through telehealth platforms for weight loss. If you're using a compounded formulation, your provider will set the dosing protocol based on the specific concentration of that compound. Always follow your provider's instructions rather than assuming the same schedule applies as with a branded product.

Nausea is the most commonly reported side effect, particularly around dose increases. A few strategies that help:

• Eat smaller meals and avoid high-fat or high-sugar foods around injection day
• Stay well hydrated throughout the week
• Inject in the evening so peak nausea occurs during sleep
• Avoid lying down immediately after eating

Constipation is also common. Increasing fiber and water intake helps most patients manage it without medication.

If side effects are severe or persistent, contact your provider. Some telehealth platforms, including JoeyMed, offer an anti-nausea add-on specifically for GLP-1 patients — something that can make the early titration weeks significantly more manageable.

A weight loss plateau on semaglutide usually comes down to one of three things: the dose isn't yet at the therapeutic level for that individual, dietary habits have crept back up to offset reduced appetite, or the body has adapted after an extended period at maintenance.

If you plateau before reaching 2.4 mg, the next dose step is the obvious first move. If you're already at 2.4 mg and weight loss has stalled, your provider may evaluate whether a different GLP-1 medication — such as tirzepatide — would be more effective for your physiology.

The titration schedule here gives you a clear picture of what to expect, but actual prescribing and dose management should happen under clinical supervision. A board-certified provider can review your health history, confirm you're a candidate for GLP-1 therapy, and adjust your protocol based on how you respond.

JoeyMed offers a straightforward three-step process: complete an online health intake, get reviewed by a licensed provider, and receive your prescription shipped discreetly to your door. No insurance required, and ongoing provider follow-up is built into the care model so dose adjustments are handled by someone who knows your case.

What is the starting dose for semaglutide for weight loss? The standard starting dose is 0.25 mg once per week for the first four weeks. This is an initiation dose designed to help your body adjust — not a therapeutic dose for weight loss.

How long does it take to reach the maintenance dose? Following the standard titration schedule, most patients reach the 2.4 mg maintenance dose around week 17. Some providers extend the schedule if tolerability is a concern, which can push the timeline to 20 weeks or longer.

Can I stay at a lower dose if it's working? Yes. If you're losing weight consistently and tolerating the medication well at a lower dose, your provider may recommend holding there rather than increasing. The goal is effective, sustainable treatment — not hitting a specific number.

What happens if I miss a semaglutide injection? If fewer than five days have passed since your scheduled injection, take the dose as soon as you remember. If you're within two days of your next scheduled dose, skip the missed one and resume your regular schedule. Don't double up.

Why does nausea get worse when the dose increases? Each dose increase temporarily raises semaglutide concentration above what your GI tract has adapted to. Nausea typically peaks in the first few days after the increase, then subsides as your body adjusts. Slowing the titration schedule can reduce this effect.

Is compounded semaglutide dosed the same way as branded Wegovy? Not necessarily. Compounded formulations vary in concentration and are not FDA-approved drugs. Your provider will set a dosing protocol specific to what you receive — follow that rather than assuming it mirrors the branded schedule.

Do I need a prescription to start semaglutide for weight loss? Yes. Semaglutide is a prescription medication in the United States. Prescriptions require provider approval following medical review, and not all patients will qualify. A telehealth intake with a licensed provider is the standard path for patients without a traditional primary care relationship.

Understanding the titration schedule before you start puts you in a much better position to stay consistent and get results. You'll know what dose comes next, why the schedule is structured the way it is, and how to handle side effects before they become a reason to quit. If you're ready to start a clinically supervised program, JoeyMed connects you with board-certified providers who manage the process from intake to delivery — no insurance required.